Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSMA-IN-3 (compound 17) is a novel, high-affinity inhibitor of Prostate-Specific Membrane Antigen (PSMA) with an inhibitory concentration (IC50) of 13 nM, showing potential for the development of an 18F-labeled radioligand for positron emission tomography (PET) imaging of PSMA in prostate cancer [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | PSMA-IN-3 (compound 17) is a novel, high-affinity inhibitor of Prostate-Specific Membrane Antigen (PSMA) with an inhibitory concentration (IC50) of 13 nM, showing potential for the development of an 18F-labeled radioligand for positron emission tomography (PET) imaging of PSMA in prostate cancer [1]. |
Molecular Weight | 923.89 |
Formula | C43H50FN7O15 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.